Authors:
SUDHOFF T
HEINS M
SOHNGEN D
LENZ V
WEHMEIER A
AUL C
MECKENSTOCK G
SCHNEIDER W
REINAUER H
HEYLL A
Citation: T. Sudhoff et al., PLASMA-LEVELS OF D-DIMER AND CIRCULATING ENDOTHELIAL ADHESION MOLECULES IN VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, European journal of haematology, 60(2), 1998, pp. 106-111
Authors:
KOBBE G
BAUSER U
RIETH C
HUNERLITURKOGLU A
SOHNGEN D
AIVADO M
AUL C
HEYLL A
Citation: G. Kobbe et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) MEDIATED MOBILIZATION OF LEUKEMIC-CELLS IN PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA EXPRESSING MYELOID ANTIGENS (MY+PH+ALL), American journal of hematology, 58(4), 1998, pp. 330-333
Authors:
SCHEID C
FUCHS M
NOCKENBERG C
HINRICHS R
DRAUBE A
WINTER S
JUNGINGER H
CHEMNITZ J
SOHNGEN D
DIEHL V
SCHULZ A
Citation: C. Scheid et al., T-CELL ACTIVATION AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - THE ROLE OF CONDITIONING, CD34+ SELECTION AND SERUM CYTOKINES, Bone marrow transplantation, 21, 1998, pp. 54-54
Authors:
HUNERLITURKOGLU A
KOBBE G
SOHNGEN D
BAUSER U
SCHNEIDER P
THIELE KP
MINNING H
SUDHOFF T
MECKENSTOCK G
STRUPP C
NIEDERSTEHOLLENBERG A
AUL C
HEYLL A
Citation: A. Hunerliturkoglu et al., HIGH-DOSE IDARUBICIN ADDED TO CVB AS AN INTENSIFIED HIGH-DOSE-CHEMOTHERAPY PROTOCOL FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED MALIGNANT-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 589-589
Authors:
SCHNEIDER P
SOHNGEN D
KOBBE G
BAUSER U
HUNERLITURKOGLU A
HEYLL A
AUL C
Citation: P. Schneider et al., HIGH-DOSE IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE FOR TREATMENT OFMULTIPLE-MYELOMA, Bone marrow transplantation, 21, 1998, pp. 707-707
Authors:
HEYLL A
SOHNGEN D
KOBBE G
SCHNEIDER P
BAUSER U
THIELE KP
WEHMEIER A
SUDHOFF T
QUENZEL EM
RIETH C
WERNET P
FISCHER J
FRICK M
AUL C
Citation: A. Heyll et al., IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE - AN INTENSIFIED HIGH-DOSEREGIMEN FOR THE TREATMENT OF MYELOMA PATIENTS, Leukemia, 11, 1997, pp. 32-34
Authors:
SOHNGEN D
BAUSER U
BOOGEN C
AUL C
FRIELING T
GERMING U
SCHNEIDER P
KOBBE G
HEYLL A
Citation: D. Sohngen et al., DOUBLE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION WITH RECOMBINANTTISSUE-PLASMINOGEN ACTIVATOR, Thrombosis and haemostasis, 78(4), 1997, pp. 1299-1300
Authors:
KORHOLZ D
KUNST D
HEMPEL L
SOHNGEN D
HEYLL A
BONIG H
GOBEL U
ZINTL F
BURDACH S
Citation: D. Korholz et al., DECREASED INTERLEUKIN-10 AND INCREASED INTERFERON-GAMMA PRODUCTION INPATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(7), 1997, pp. 691-695
Authors:
AUL C
GERMING U
GATTERMANN N
SOHNGEN D
HEYLL A
Citation: C. Aul et al., PROGNOSTIC-SIGNIFICANCE OF SERUM THYMIDIN E KINASE IN THE MYELODYSPLASTIC SYNDROME, Deutsche Medizinische Wochenschrift, 121(37), 1996, pp. 1113-1118
Authors:
GERMING U
SOHNGEN D
HEYLL A
KOBBE G
AUL C
SCHNEIDER W
Citation: U. Germing et al., SEVERE MUSCULOSKELETAL PAIN AFTER CYCLOSPORINE-A TREATMENT IN A PATIENT UNDERGOING ALLOGENEIC BMT, Oncology Reports, 3(4), 1996, pp. 775-776
Authors:
FISCHER J
KOBBE G
SOHNGEN D
HEYLL A
KOGLER G
WERNET P
Citation: J. Fischer et al., G-CSF PRIMING AND PBPC APHERESIS IN UNRELATED DONORS FOR ALLOGRAFTING- 14 MONTHS EXPERIENCE, Experimental hematology, 24(9), 1996, pp. 673-673
Authors:
KORHOLZ D
KUNST D
HEMPEL L
SOHNGEN D
HEYLL A
MAUZKORHOLZ C
ZINTL F
BURDACH S
Citation: D. Korholz et al., HUMORAL IMMUNODEFICIENCY IN PATIENTS AFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(6), 1996, pp. 1123-1130
Authors:
KORHOLZ D
HEMPEL L
KUNST D
SOHNGEN D
HEYLL A
ZINTL F
BURDACH S
Citation: D. Korholz et al., A DECREASED INTERLEUKIN-10 AND INCREASED INTERFERON-GAMMA PRODUCTION IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE IS CAUSING A HUMORAL IMMUNODEFICIENCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 2563-2563
Authors:
SOHNGEN D
KUNTZ BME
HEINS M
SPECKER C
BACH D
BURK M
AUL C
SCHNEIDER W
Citation: D. Sohngen et al., ACQUIRED FACTOR-VIII-C INHIBITOR ANTIBODI ES IN NONHEMOPHILIC PATIENTS, Infusionstherapie und Transfusionsmedizin, 22, 1995, pp. 56-59
Authors:
BURKHARDMEIER U
SOHNGEN D
SCHULTHEISS HP
GREINACHER A
SCHWARTZKOPFF B
VOGT M
HEYLL A
SCHNEIDER W
Citation: U. Burkhardmeier et al., HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II - SUCCESSFUL USE OF ORGARAN (ORG-10172) IN INTENSIVE-CARE PATIENTS, Intensive care medicine, 21(6), 1995, pp. 542-543
Authors:
SOHNGEN D
TSAMALOUKAS AG
FREHEN D
SPECKER C
HEINS M
RADEMACHER I
SCHNEIDER W
Citation: D. Sohngen et al., ANTIPHOSPHOLIPID ANTIBODIES-RELATED CLINICAL-FEATURES IN A PATIENT WITH THYMITIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1278-1278
Authors:
ENCZMANN J
KNIPPER A
UHRBERG M
SCHUCH B
HEYLL A
SOHNGEN D
SCHNEIDER W
BURDACH S
GOBEL U
WERNET P
Citation: J. Enczmann et al., MOLECULAR HISTOCOMPATIBILITY MATCHING-STRATEGY FOR UNRELATED BONE-MARROW TRANSPLANTATION, Experimental hematology, 23(8), 1995, pp. 744-744
Authors:
HEYLL A
KOBBE G
SOHNGEN D
MECKENSTOCK G
AUL C
ILLES A
KOGLER G
WERNET P
Citation: A. Heyll et al., DEPENDENCE OF PERIPHERAL-BLOOD STEM-CELL (PBSC) YIELD COLLECTED IN PATIENTS WITH MALIGNANT-LYMPHOMA AND MULTIPLE-MYELOMA ON THE EXTENT OF PREVIOUS RADIOCHEMOTHERAPY AND THE DOSE OF G-CSF, Experimental hematology, 23(8), 1995, pp. 758-758
Authors:
STEGE H
NURNBERGER W
BURDACH S
HEYLL A
SOHNGEN D
LEHMANN P
RUZICKA T
KRUTMANN J
Citation: H. Stege et al., THE USE OF PHOTOCHEMOTHERAPY IN THE MANAGEMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) - 2 CASE-REPORTS, Experimental hematology, 23(8), 1995, pp. 859-859